Pulmonary Embolism
Pulmonary Embolism is a cardiovascular condition. The available data here only indicates that it has one listed support association and one listed avoid association, but it does not provide details about symptoms, causes, or how it develops.
Pulmonary embolism is a cardiovascular condition. This page offers a simple, neutral overview of the condition.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
May not suit people with this condition
Supplements and practices linked to problems for people with this condition.
Strength TrainingpracticeUnclear
An acute pulmonary embolism is a medical emergency, and exertion can worsen hemodynamic instability.
Open the Strength Training page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this conditionNothing in this library is currently recorded as helping with Pulmonary Embolism. That means nothing is on file — not that nothing exists. Only 107 of 338 catalogued supplements have a written-up profile so far.
What to avoid
Interventions recorded as making it worse1 listedHighest probability
- →PracticesStrength TrainingCertaintyLowSourceReference knowledge
An acute pulmonary embolism is a medical emergency, and exertion can worsen hemodynamic instability.
Open Strength TrainingRationale
Acute pulmonary embolism is a medical emergency; any exertion can worsen hemodynamic instability.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Pulmonary Embolism is a cardiovascular condition. The available data here only indicates that it has one listed support association and one listed avoid association, but it does not provide details about symptoms, causes, or how it develops.
Because the information is limited, this page serves as a brief reference rather than a full description of the condition. For questions about Pulmonary Embolism or how it may relate to a specific situation, a clinician can help interpret the details in context.
Evidence-backed options
Sildenafil is listed as a very low-probability clinical option that may help in Pulmonary Embolism. Because the evidence is very limited, this should be read as a signal of possible benefit rather than as a well-established treatment effect.
For a condition like Pulmonary Embolism, evidence-backed options are typically interpreted cautiously and in context with the overall clinical picture. A very low evidence rating means there is not enough strong support to rely on this finding alone, and it does not show how Sildenafil compares with standard care or whether it is appropriate for every case.
This kind of summary is meant to help readers understand where there is at least some clinical evidence, even when that evidence is sparse. For any medical condition, a clinician can help interpret whether an option like Sildenafil is relevant in a specific situation.
What to avoid
For Pulmonary Embolism, the main item listed to avoid is Strontium. This means it is considered a combination to steer clear of in this condition, based on the available pharmacology reference.
Because the evidence here is limited to a pharmacology reference, it is best read as a precaution rather than a broad list of every possible concern. If someone has Pulmonary Embolism and is considering any supplement or product, especially one containing Strontium, a clinician can help check whether it is appropriate in the context of their overall treatment and risk factors.